
Loading, please wait...

Loading, please wait...

Colorectal cancer (CRC) remains a significant public health burden. Unfortunately, many patients avoid traditional screening methods such as colonoscopy or stool-based tests. Blood-based CRC screening offers a non-invasive alternative that could improve population health outcomes. By providing a simpler testing modality, healthcare providers can reach individuals who previously declined all screening options. Consequently, this approach may significantly reduce cancer-related mortality in the long term.
This study utilized a validated discrete-event simulation model to assess 10,000 individuals starting at age 45. Researchers analyzed clinical outcomes and cost-effectiveness from a healthcare sector perspective. Evidence from randomized controlled trials informed patient preferences for various screening options. Furthermore, the researchers modeled adherence using both ideal and longitudinal real-world scenarios. The findings indicate that adding blood tests to the screening arsenal yields substantial benefits. Specifically, CRC deaths averted increased between 68% and 247% in revealed preference scenarios compared to no screening.
Cost-effectiveness remains a critical factor for implementing any new medical technology. The analysis found that blood tests fall well within the standard willingness-to-pay threshold of $100,000 per quality-adjusted life-year (QALY). Incremental cost-effectiveness ratios (ICERs) ranged from $30,464 to $85,497 across different scenarios. Therefore, these tests provide high value while addressing the screening gap. Additionally, the non-invasive nature of the test helps patients overcome common psychological and logistical barriers associated with colonoscopy.
Despite these promising results, some limitations exist. The study relied on informed assumptions for natural history and longitudinal adherence due to limited real-world data. However, the simulation demonstrates that blood-based CRC screening can lead to cost-effective increases in life-saving outcomes. Healthcare systems should consider these findings when developing inclusive screening programs for resistant populations.
No, it serves as an alternative for patients who decline traditional methods, helping to increase overall screening rates and catch cancer earlier.
Blood tests are cost-effective because they significantly increase screening participation among individuals who otherwise would not be screened at all, reducing long-term treatment costs.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new economic evaluation shows that blood-based colorectal cancer screening is cost-effective and significantly reduces mortality among unscreened individu...
4 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today